Skip to main content

Table 6 Projected annual budget and clinical impact of new versus current market share for uterotonics

From: Cost-effectiveness and budget impact of heat-stable carbetocin compared to oxytocin and misoprostol for the prevention of postpartum hemorrhage (PPH) in women giving birth in India

 

2022

2023

2024

2025

2026

Total Births

13,979,677

14,124,691

14,271,210

14,419,249

14,568,823

Total Costs ($)

 Current environment

1,975,973,855

1,996,471,093

2,017,180,954

2,038,105,644

2,059,247,390

 New environment

1,975,920,321

1,995,930,198

2,015,491,503

2,034,415,603

2,053,845,363

 Budget impact

-53,534

-540,895

-1,689,452

-3,690,041

-5,402,026

Total Costs (₹)

 Current environment

147,506,448,280

149,036,567,126

150,582,558,253

152,144,586,306

153,722,817,641

 New environment

147,502,451,954

148,996,189,314

150,456,440,696

151,869,124,773

153,319,556,370

 Budget impact

-3,996,326

-40,377,812

-126,117,556

-275,461,533

-403,261,272

Total PPH Events

 Current environment

2,633,715

2,661,035

2,688,639

2,716,529

2,744,708

 New environment

2,632,219

2,645,917

2,640,648

2,611,835

2,592,148

 Clinical impact

-1,496

-15,118

-47,991

-104,694

-152,560